619 related articles for article (PubMed ID: 25886468)
1. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
[TBL] [Abstract][Full Text] [Related]
2. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
3. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.
Meng H; Liu Y; Lai L
Acc Chem Res; 2015 Aug; 48(8):2242-50. PubMed ID: 26237215
[TBL] [Abstract][Full Text] [Related]
4. Molecular evolution of cyclooxygenase and lipoxygenase.
Toh H; Yokoyama C; Tanabe T; Yoshimoto T; Yamamoto S
Prostaglandins; 1992 Oct; 44(4):291-315. PubMed ID: 1438882
[TBL] [Abstract][Full Text] [Related]
5. Reduced lipoxygenase and cyclooxygenase mediated signaling in PBMC of atopic dermatitis patients.
Mihály J; Gericke J; Törőcsik D; Gáspár K; Szegedi A; Rühl R
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():35-42. PubMed ID: 23603610
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal β-barrel domain of mammalian lipoxygenases including mouse 5-lipoxygenase is not essential for catalytic activity and membrane binding but exhibits regulatory functions.
Walther M; Hofheinz K; Vogel R; Roffeis J; Kühn H
Arch Biochem Biophys; 2011 Dec; 516(1):1-9. PubMed ID: 21951814
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation.
Kaur G; Silakari O
Bioorg Chem; 2018 Oct; 80():24-35. PubMed ID: 29864685
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation.
Lapenna D; Ciofani G; Pierdomenico SD; Neri M; Cuccurullo C; Giamberardino MA; Cuccurullo F
Biochim Biophys Acta; 2009 Jan; 1790(1):25-30. PubMed ID: 18950686
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Mechanism of the Hydrogen Abstraction from Arachidonic Acid Catalyzed by the Human Enzyme 15-Lipoxygenase-2. A Quantum Mechanics/Molecular Mechanics Free Energy Simulation.
Suardíaz R; Jambrina PG; Masgrau L; González-Lafont À; Rosta E; Lluch JM
J Chem Theory Comput; 2016 Apr; 12(4):2079-90. PubMed ID: 26918937
[TBL] [Abstract][Full Text] [Related]
12. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
14. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of R and S isoforms of 12-lipoxygenases: homology modeling and docking studies.
Aparoy P; Leela T; Reddy RN; Reddanna P
J Mol Graph Model; 2009 Feb; 27(6):744-50. PubMed ID: 19147381
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
17. Alterations of lipoxygenase specificity by targeted substrate modification and site-directed mutagenesis.
Walther M; Ivanov I; Myagkova G; Kuhn H
Chem Biol; 2001 Aug; 8(8):779-90. PubMed ID: 11514227
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2.
Jisaka M; Kim RB; Boeglin WE; Brash AR
J Biol Chem; 2000 Jan; 275(2):1287-93. PubMed ID: 10625675
[TBL] [Abstract][Full Text] [Related]
19. Eicosanoid Diversity of Stony Corals.
Lõhelaid H; Samel N
Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29301345
[TBL] [Abstract][Full Text] [Related]
20. Affinity labeling of the rabbit 12/15-lipoxygenase using azido derivatives of arachidonic acid.
Romanov S; Wiesner R; Myagkova G; Kuhn H; Ivanov I
Biochemistry; 2006 Mar; 45(11):3554-62. PubMed ID: 16533037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
